Sarah Meibusch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarah meibusch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarah Meibusch Today - Breaking & Trending Today

Best Translational Research Awarded At AusMedtech 2024

Best Translational Research Awarded At AusMedtech 2024
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South Australia , Michelle Gallaher Cerulea , Sarah Meibusch Oneventures , Joseph Ischia , Mark Lawler West Pharmaceuticals , Stage Innovation Forum , Jiffystent Inserter , Chief Executive Officer , Emergency Room , Michelle Gallaher , Teddie Walker , Sarah Meibusch , Steve Burnell , Mark Lawler , West Pharmaceuticals ,

AusMedtechInvest Keynote And Panel Speakers Announced

AusMedtechInvest Keynote And Panel Speakers Announced
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South Australia , Amandeep Hansra , Sarah Meibusch , Alex Romero , Fredrik Nyberg , Steve Burnell , Rowena Gray , Rohan Gray , Adelaide Convention Centre On , Brandon Capital , Main Sequence , Adelaide Convention Centre , Medical Angels , Main Sequence Ventures , Managing Director , Founding Partner , Oncores Medical ,

Best early-stage project at awarded at AusMedtech 2023

Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers. ....

United Kingdom , South Australia , Sarah Meibusch Oneventures , Michelle Hill , Michelle Gallaher Opyl , Stage Innovation Forum , Berghofer Precision Systems Biomedicine Laboratory , Translational Research At Ausmedtech , Best Translational Research , Associate Professor Michelle Hill , Prof Hill , Systems Biomedicine Laboratory , Proteomics Clinical Applications , Sarah Meibusch , Ashley Wittorf , Johnson Medtech , Michelle Gallaher , Teddie Walker ,

Axial Therapeutics tops up funding for phase 2 autism trial with $37M series C

Axial Therapeutics has picked up $37.3 million to bankroll a midstage test in autism and fund further work on neurological diseases. The Woburn, Massachusetts-based biotech began the phase 2b study in August and expects primary completion next December. ....

New South Wales , United States , Sarkis Mazmanian , Seventure Nora Frey , Makoto Ohori , Sarah Meibusch , University Of Tokyo Innovation Platform Company , Axial Therapeutics , Tokyo Innovation Platform Company , Chief Scientific Officer Sarkis Mazmanian , Axial Biotech , Venture Capital , Ongwood Founders Fund , Neurological Disorders ,

Nutromics wins best early-stage project award

Date Time
Nutromics wins best early-stage project award
Nutromics took home the coverted ‘Best Translational Research’ award at AusMedtech 2021’s Early-Stage Investment Forum, after winning the pitching event judged by an expert investment panel.
Nutromics’ Head of Commercial and Intellectual Property Ms Rosie Stramandinoli presented the company’s wearable Continuous Molecular Monitoring (CMM) platform which can measure a wide array of molecular targets continuously and in real time, including drugs, hormones, metabolites, and proteins. This platform technology enables clinicians to receive continuous real-time molecular data to accurately dose a patient and keep them within a narrow therapeutic range. Nutromics’ vision is to create a world with zero preventable deaths due to the lack of timely, molecular-level data. ....

New Zealand , Rosie Stramandinoli , Kathy Connell , Jamie Platt , Sarah Meibusch , Steven Suchting , Business Development Strategy , Ip Group , Stage Investment Forum , Translational Research , Business Development , Best Translational Research , Intellectual Property Ms Rosie Stramandinoli , Continuous Molecular Monitoring , Early Stage Investment Forum , Strategy Manager Jamie Platt , Cone Ventures , Investment Director , Senior Director , New Ventures , Johnson Innovation , Strategy Manager , Victorian Government , Ghost State , Biotechnology Industry , New Zealand ,